DISAPPEARANCE OF ANTI-DRUG ANTIBODIES TO INFLIXIMAB AND ADALIMUMAB AFTER ADDITION OF AN IMMUNOMODULATOR IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Anne Strik  1    
1  - Amsterdam/NL

Pathway
IBD, Paediatrics, Surgery

Conference
UEG Week 2016


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing